[Federal Register Volume 64, Number 232 (Friday, December 3, 1999)]
[Notices]
[Pages 67926-67927]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-31341]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Disease; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose

[[Page 67927]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the contract proposals, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel. ZDK1 GRB-D (C4).
    Date: November 29, 1999.
    Time: 3:30 PM to 5:30 PM.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Natcher Bldg., 45 Center 
Drive, Room 6AS-37, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Ann A. Hagan, Chief, Review Branch National 
Institute of Diabetes, Digestive and Kidney Diseases National 
Institutes of Health, PHS, DHHS Rm. 6AS37, Bldg., 45 Bethesda, MD 
20892 (301) 594-8886.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: November 24, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-31341 Filed 12-2-99; 8:45 am]
BILLING CODE 4140-01-M